|
1
|
Fraser WD: Hyperparathyroidism. Lancet.
374:145–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bilezikian JP, Brandi ML, Eastell R,
Silverberg SJ, Udelsman R, Marcocci C and Potts JT Jr: Guidelines
for the management of asymptomatic primary hyperparathyroidism:
Summary statement from the fourth international workshop. J Clin
Endocrinol Metab. 99:3561–3569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng SP, Lee JJ, Liu TP, Yang PS, Liu SC,
Hsu YC and Liu CL: Quality of life after surgery or surveillance
for asymptomatic primary hyperparathyroidism: A meta-analysis of
randomized controlled trials. Medicine (Baltimore). 94:e9312015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng SP, Lee JJ, Liu TP, Yang TL, Chen
HH, Wu CJ and Liu CL: Parathyroidectomy improves symptomatology and
quality of life in patients with secondary hyperparathyroidism.
Surgery. 155:320–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elliott DD, Monroe DP and Perrier ND:
Parathyroid histopathology: Is it of any value today? J Am Coll
Surg. 203:758–765. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drueke T, Martin D and Rodriguez M: Can
calcimimetics inhibit parathyroid hyperplasia? Evidence from
preclinical studies. Nephrol Dial Transplant. 22:1828–1839. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bingham EL, Cheng SP, Woods Ignatoski KM
and Doherty GM: Differentiation of human embryonic stem cells to a
parathyroid-like phenotype. Stem Cells Dev. 18:1071–1080. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thomopoulou GE, Tseleni-Balafouta S,
Lazaris AC, Koutselini H, Kavantzas N and Davaris PS:
Immunohistochemical detection of cell cycle regulators, Fhit
protein and apoptotic cells in parathyroid lesions. Eur J
Endocrinol. 148:81–87. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shan L, Nakamura Y, Nakamura M, Yokoi T
and Kakudo K: Genetic alterations in primary and secondary
hyperparathyroidism. Pathol Int. 48:569–574. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Westin G, Björklund P and Akerström G:
Molecular genetics of parathyroid disease. World J Surg.
33:2224–2233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng SP, Lee JJ, Liu TP, Chen HH, Wu CJ
and Liu CL: Aluminum overload hampers symptom improvement following
parathyroidectomy for secondary hyperparathyroidism. World J Surg.
38:2838–2844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng SP, Yin PH, Chang YC, Lee CH, Huang
SY and Chi CW: Differential roles of leptin in regulating cell
migration in thyroid cancer cells. Oncol Rep. 23:1721–1727.
2010.PubMed/NCBI
|
|
13
|
Au AY, McDonald K, Gill A, Sywak M,
Diamond T, Conigrave AD and Clifton-Bligh RJ: PTH mutation with
primary hyperparathyroidism and undetectable intact PTH. N Engl J
Med. 359:1184–1186. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benjamini Y and Yekutieli D: False
discovery rate-adjusted multiple confidence intervals for selected
parameters. J Am Stat Assoc. 100:71–81. 2005. View Article : Google Scholar
|
|
15
|
Cheng SP, Doherty GM, Chang YC and Liu CL:
Leptin: The link between overweight and primary
hyperparathyroidism? Med Hypotheses. 76:94–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dwight T, Nelson AE, Theodosopoulos G,
Richardson AL, Learoyd DL, Philips J, Delbridge L, Zedenius J, Teh
BT, Larsson C, et al: Independent genetic events associated with
the development of multiple parathyroid tumors in patients with
primary hyperparathyroidism. Am J Pathol. 161:1299–1306. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Newey PJ, Nesbit MA, Rimmer AJ, Attar M,
Head RT, Christie PT, Gorvin CM, Stechman M, Gregory L, Mihai R, et
al: Whole-exome sequencing studies of nonhereditary (sporadic)
parathyroid adenomas. J Clin Endocrinol Metab. 97:E1995–E2005.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Costa-Guda J and Arnold A: Genetic and
epigenetic changes in sporadic endocrine tumors: Parathyroid
tumors. Mol Cell Endocrinol. 386:46–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JY, Kim SY, Mo EY, Kim ES, Han JH,
Maeng LS, Lee AH, Eun JW, Nam SW and Moon SD: Upregulation of FGFR1
expression is associated with parathyroid carcinogenesis in HPT-JT
syndrome due to an HRPT2 splicing mutation. Int J Oncol.
45:641–650. 2014.PubMed/NCBI
|
|
20
|
Segiet OA, Deska M, Michalski M,
Gawrychowski J and Wojnicz R: Molecular profiling in primary
hyperparathyroidism. Head Neck. 37:299–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shan L, Nakamura M, Nakamura Y, Inoue D,
Morimoto S, Yokoi T and Kakudo K: Comparative analysis of clonality
and pathology in primary and secondary hyperparathyroidism.
Virchows Arch. 430:247–251. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y, Hogue J, Dixit D, Koh J and Olson
JA Jr: Functional and genetic studies of isolated cells from
parathyroid tumors reveal the complex pathogenesis of parathyroid
neoplasia. Proc Natl Acad Sci USA. 111:3092–3097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tominaga Y, Kohara S, Namii Y, Nagasaka T,
Haba T, Uchida K, Numano M, Tanaka Y and Takagi H: Clonal analysis
of nodular parathyroid hyperplasia in renal hyperparathyroidism.
World J Surg. 20:744–750; discussion 750–752. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tharmalingam S, Daulat AM, Antflick JE,
Ahmed SM, Nemeth EF, Angers S, Conigrave AD and Hampson DR:
Calcium-sensing receptor modulates cell adhesion and migration via
integrins. J Biol Chem. 286:40922–40933. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomaschitz A, Ritz E, Pieske B, Rus-Machan
J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer
A, Mrak P, et al: Aldosterone and parathyroid hormone interactions
as mediators of metabolic and cardiovascular disease. Metabolism.
63:20–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Porsti I, Fan M, Kööbi P, Jolma P,
Kalliovalkama J, Vehmas TI, Helin H, Holthofer H, Mervaala E, Nyman
T and Tikkanen I: High calcium diet down-regulates kidney
angiotensin-converting enzyme in experimental renal failure. Kidney
Int. 66:2155–2166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brown JM, Williams JS, Luther JM, Garg R,
Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK and Vaidya A:
Human interventions to characterize novel relationships between the
renin-angiotensin-aldosterone system and parathyroid hormone.
Hypertension. 63:273–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pons F, Torregrosa JV and Fuster D:
Biological factors influencing parathyroid localization. Nucl Med
Commun. 24:121–124. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang TS, Lee JJ, Lin YC and Cheng SP:
Fluorodeoxyglucose-avid parathyroid adenoma mimicking thyroid
incidentaloma. ANZ J Surg. 80:763–764. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hindié E, Zanotti-Fregonara P, Tabarin A,
Rubello D, Morelec I, Wagner T, Henry JF and Taïeb D: The role of
radionuclide imaging in the surgical management of primary
hyperparathyroidism. J Nucl Med. 56:737–744. 2015. View Article : Google Scholar : PubMed/NCBI
|
